What does this research mean for the field?

A novel tumor-only, reference-free pipeline (PROMIS) accurately detects microsatellite instability across multiple cancer types and sequencing assays by leveraging intrasample variability. Novelty: ClaimNovelty.METHODOLOGICAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To develop and validate PROMIS, a reference-free, tumor-only pipeline that detects microsatellite instability by modeling repeat-length intrasample variability.

August 23, 2026Computational and Structural Biotechnology JournalOpen Access

Reference-free microsatellite instability detection from tumor sequencing using intrasample variability modeling

View Full Paper

Ask AI

Bookmark

Authors

GVGeorgios VlachosUniversity of Graz TMTina MoserMedical University of Graz MPMitesh PatelRutgers, The State University of New Jersey

Discussion

Member takes

Implication

Validation study reveals accurate reference-free microsatellite instability detection across multiple cancer types, indicating strong utility for tumor-only sequencing and liquid biopsy.

Key Points

To develop and validate PROMIS, a reference-free, tumor-only pipeline that detects microsatellite instability by modeling repeat-length intrasample variability.
Modeled repeat-length distributions across predefined microsatellite loci with a discrete mixture framework to distinguish stable germline profiles from unstable loci and calculate an aggregate instability score.
Benchmarked performance across The Cancer Genome Atlas colorectal (CRC), endometrial (UCEC), and gastric (STAD) cancer cohorts, evaluated in silico dilutions down to 3% tumor fraction, and tested prostate and CRC cell-free DNA panels.
PROMIS achieved an overall AUC of 0.995 across TCGA cohorts, with cohort-specific AUCs of 1.00 in CRC and STAD, and 0.999 in UCEC.
Maintained robust diagnostic accuracy down to a 3% tumor fraction with reduced loci sets and demonstrated high concordance with orthogonal classifications in cell-free DNA assays.

Cite This Study

Vlachos et al. (2026) studied this question.

synapsesocial.com/papers/6a8aad167677a341144454de https://doi.org/10.34133/csbj.0219

View Full Paper

Ask AI

Bookmark

Implication

Validation study reveals accurate reference-free microsatellite instability detection across multiple cancer types, indicating strong utility for tumor-only sequencing and liquid biopsy.

Reference-free microsatellite instability detection from tumor sequencing using intrasample variability modeling

Discussion

Member takes

Implication

Key Points

Cite This Study

Reference-free microsatellite instability detection from tumor sequencing using intrasample variability modeling

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider